129.6K
Downloads
82
Episodes
Official podcast of the Breast Cancer Research Foundation
Episodes
Tuesday Mar 01, 2022
Tuesday Mar 01, 2022
Triple negative breast cancer (TNBC) makes up about 15 percent of all the breast cancers diagnosed. And, better therapeutic strategies are urgently needed to treat this breast cancer subtype. BCRF Investigator, Dr. Elisa Port is working to combat drug resistance in TNBC by developing a drug for the protein PRKCQ—a promising therapeutic target that may make TNBC more responsive to chemotherapy.
Comments (2)
To leave or reply to comments, please download free Podbean or
Not going back on chemo, use THC Oil
Thursday Oct 13, 2022
Hello my name is Catherine I have Stage 4 Breast Cancer. Was diagnosed in 2019 with Thriple Negative Breast Cancer got 3 years remission and it spread to both my lungs.
Thursday Oct 13, 2022
To leave or reply to comments,
please download free Podbean App.